Article: Preventing side effects of radiographic contrast agents with N-acetylcysteine.

Eighty-three patients with chronic renal insufficiency (mean serum creatinine, 2.4 mg/dl) who were undergoing computed tomography with a contrast agent were randomly assigned to receive N-acetylcysteine (NAC) or placebo (blinding not specified). The dosage of NAC was 600 mg orally twice daily, on the day before and the day of administration of the contrast agent. Both groups received intravenous hydration with 0.45% saline. An increase of at least 0.5 mg/dl in the serum creatinine concentration 48 hours after administration of the contrast agent was seen in 2.4% of the patients in the NAC group, compared with 21% of those in control group (risk reduction = 89%; p = 0.01). ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!